Exact Sciences Corp (NAS:EXAS)
$ 53.79 0.27 (0.5%) Market Cap: 9.93 Bil Enterprise Value: 11.78 Bil PE Ratio: 0 PB Ratio: 3.16 GF Score: 78/100

Exact Sciences Corp at Goldman Sachs Global Healthcare Conference (Virtual) Transcript

Jun 09, 2021 / 06:10PM GMT
Release Date Price: $119.2 (+4.53%)
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst

Good afternoon, everyone. I'm Matt Sykes, senior research analyst for life sciences tools and diagnostics at Goldman Sachs. I have the pleasure of welcoming Exact Sciences management to our conference today. Today, we have Jeff Elliott, Executive Vice President, Chief Financial and Operating Officer; and Jake Orville, the General Manager Pipeline. Jeff, Jake, thanks so much for joining us.

Jeffrey T. Elliott
Exact Sciences Corporation - Executive VP, CFO & COO

Thanks, Matt. Great to be here.

Questions & Answers

Matthew Carlisle Sykes;Jeffrey T. Elliott
Goldman Sachs Group, Inc., Research Division - Research Analyst;Exact Sciences

Great. Maybe we'll just start out, and I'll kind of let you set the stage initially and maybe talk about some of the recent trends you've seen, your performance in the first quarter and some of your key thoughts and drivers for the balance of this year.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot